Oxford Covid vaccine safe for adults
By AFP
November 20, 2020
PARIS: A leading Covid-19 vaccine candidate has shown to safely produce a robust immune response in healthy older adults, its British makers said on Thursday as it released its phase 2 trial results. The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in people aged 56 and over than in younger people -- a significant finding given that Covid-19 disproportionately causes severe illness among seniors.
-
King Charles' Andrew Decision Labelled 'long Overdue' -
Timothee Chalamet 'forever Indebted' To Fan Over Kind Gesture -
Columbia University Sacks Staff Over Epstein Partner's ‘backdoor’ Admission -
Ozzy Osbourne's Family Struggles Behind Closed Doors -
Dua Lipa Claims Long-distance Relationship 'never Stops Being Hard' -
BTS Moments Of Taylor Swift's 'Opalite' Music Video Unvieled: See Photos -
Robin Windsor's Death: Kate Beckinsale Says It Was Preventable Tragedy -
Rachel Zoe Shares Update On Her Divorce From Rodger Berman -
Kim Kardashian Officially Takes Major Step In Romance With New Boyfriend Lewis Hamilton -
YouTube Tests Limiting ‘All’ Notifications For Inactive Channel Subscribers -
'Isolated And Humiliated' Andrew Sparks New Fears At Palace -
Google Tests Refreshed Live Updates UI Ahead Of Android 17 -
Ohio Daycare Worker 'stole $150k In Payroll Scam', Nearly Bankrupting Nursery -
Michelle Yeoh Gets Honest About 'struggle' Of Asian Representation In Hollywood -
Slovak Fugitive Caught At Milano-Cortina Olympics To Watch Hockey -
King Charles Receives Exciting News About Reunion With Archie, Lilibet